Armata Pharmaceuticals (ARMP) Retained Earnings: 2013-2017
Historic Retained Earnings for Armata Pharmaceuticals (ARMP) over the last 5 years, with Dec 2017 value amounting to -$394.2 million.
- Armata Pharmaceuticals' Retained Earnings fell 2.59% to -$402.0 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$402.0 million, marking a year-over-year decrease of 2.59%. This contributed to the annual value of -$394.2 million for FY2017, which is 3.37% down from last year.
- Per Armata Pharmaceuticals' latest filing, its Retained Earnings stood at -$394.2 million for FY2017, which was down 3.37% from -$381.4 million recorded in FY2016.
- Armata Pharmaceuticals' 5-year Retained Earnings high stood at -$362.0 million for FY2014, and its period low was -$394.2 million during FY2017.
- In the last 3 years, Armata Pharmaceuticals' Retained Earnings had a median value of -$381.4 million in 2016 and averaged -$379.4 million.
- In the last 5 years, Armata Pharmaceuticals' Retained Earnings climbed by 6.00% in 2014 and then dropped by 5.20% in 2016.
- Over the past 5 years, Armata Pharmaceuticals' Retained Earnings (Yearly) stood at -$385.1 million in 2013, then grew by 6.00% to -$362.0 million in 2014, then declined by 0.14% to -$362.5 million in 2015, then fell by 5.20% to -$381.4 million in 2016, then dropped by 3.37% to -$394.2 million in 2017.